Felis catus gammaherpesvirus 1; a widely endemic potential pathogen of domestic cats  by Beatty, Julia A. et al.
Felis catus gammaherpesvirus 1; a widely endemic potential pathogen
of domestic cats
Julia A. Beatty a,n,1, Ryan M. Troyer b,1, Scott Carver c, Vanessa R. Barrs a, Fanny Espinasse a,
Oliver Conradi a, Kathryn Stutzman-Rodriguez b, Cathy C. Chan d, Séverine Tasker e,
Michael R. Lappin f, Sue VandeWoude b
a Valentine Charlton Cat Centre, Faculty of Veterinary Science and Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney,
NSW 2006, Australia
b Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA
c School of Biological Sciences, University of Tasmania, Hobart, Tas 7001, Australia
d The Animal Doctors Pte Ltd., Singapore
e School of Veterinary Sciences, University of Bristol, Langford, Bristol BS40 5DU, UK
f Department of Clinical Sciences, Colorado State University, Fort Collins, CO 80522, USA
a r t i c l e i n f o
Article history:
Received 22 March 2014
Returned to author for revisions
7 April 2014
Accepted 7 May 2014
Available online 29 May 2014
Keywords:
Gammaherpesvirus
Feline
Molecular epidemiology
Copathogen
Transmission
a b s t r a c t
Felis catus gammaherpesvirus 1 (FcaGHV1), recently discovered in the USA, was detected in domestic
cats in Australia (11.4%, 95% conﬁdence interval 5.9–19.1, n¼110) and Singapore (9.6%, 95% conﬁdence
interval 5.9–14.6, n¼176) using qPCR. FcaGHV1 qPCR positive cats were 2.8 times more likely to be sick
than healthy. Risk factors for FcaGHV1 detection included being male, increasing age and coinfection
with pathogenic retroviruses, feline immunodeﬁciency virus (FIV) or feline leukaemia virus. FcaGHV1
DNA was detected in multiple tissues from infected cats with consistently high virus loads in the small
intestine. FcaGHV1 viral load was signiﬁcantly higher in FIV-infected cats compared with matched
controls, mimicking increased Epstein–Barr virus loads in human immunodeﬁciency virus-infected
humans. FcaGHV1 is endemic in distant geographic regions and is associated with being sick and with
coinfections. Horizontal transmission of FcaGHV1 is supported, with biting being a plausible route.
A pathogenic role for FcaGHV1 in domestic cats is supported.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Gammaherpesviruses (GHVs) are one of three subfamilies in the
family Herpesviridae, order Herpesvirales (King et al., 2012). GHVs are
classiﬁed within four genera; Lymphocryptovirus, Rhandinovirus,
Macavirus and Percavirus. They infect a diverse range of vertebrates
including humans and other primates, several ruminants, squirrels,
badgers and sea lions (King et al., 2012). Persistent infection is
characteristic of GHVs but their pathogenicity is variable. In the virus's
natural host, infection is often inapparent as long as antiviral immu-
nity is maintained. In the absence of an effective immune response,
either because of immune dysfunction or infection of a susceptible but
non-adapted host, GHVs cause devastating diseases including lym-
phoma and malignant catarrhal fever.
We recently reported the molecular identiﬁcation of the ﬁrst GHV
of the domestic cat, Felis catus gammaherpesvirus 1 (FcaGHV1), bobcat
(LruGHV1), both clustering in the Percavirus genus, and a puma GHV
(PcoGHV1) most closely related the rhadinoviruses (Troyer et al.,
2014). The global domestic cat population is estimated at 600 million
(Peterson et al., 2012). The position of cats as the world's principal
companion animal drives an expanding market for specialist veter-
inary care (Batson, 2008). With an owned cat population of 74 million
in North America alone, demand for vaccines and therapeutics
targeting a novel feline pathogen is likely to be high (AVMA, 2012).
Increasing levels of cat-human contact demands vigilance regarding
the zoonotic potential of novel feline infections; zoonoses are the
predominant source of emerging infectious diseases (Jones et al.,
2008). Feline pathogens may also impact wildlife biodiversity. Patho-
gen spill-over from free-roaming cats accompanying expanding
human habitats presents a potential risk to sympatric wildlife popula-
tions (Bevins et al., 2012). Thus, determination of the pathogenic
potential of FcaGHV1 is a priority for feline, human and wildlife health.
The development of a vaccine for the GHV Epstein–Barr virus
(EBV), a lymphocryptovirus, has been identiﬁed as a signiﬁcant
goal for human medicine (Cohen et al., 2011), though the absence
of a suitable natural host-virus model is a hurdle to progress in
this area (Yajima et al., 2008). EBV is responsible for 200,000 new
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malignancies/year, or 2% of the world's cancers (Thun et al., 2010;
Fukayama and Ushiku, 2011), as well as signiﬁcant morbidity from
infectious mononucleosis in young adults (Macsween et al., 2010).
It was the role of human GHVs as copathogens in HIV infection
(Cesarman, 2011) that raised suspicion for the existence of a GHV
in the domestic cat (Beatty et al., 2012). In HIV-infected patients,
EBV is causal in 80% of non-Hodgkin's lymphomas (Gloghini et al.,
2013). Cats infected with feline immunodeﬁciency virus (FIV) are
susceptible to immune dysfunction and aggressive B cell lympho-
mas that mirror the consequences of HIV infection (Vahlenkamp
et al., 2006; Shelton et al., 1990). Therefore, if FcaGHV is revealed
to be a feline pathogen, its suitability as natural model for human
GHV infections would be relevant.
We reported widespread FcaGHV1 infection of free-ranging
feral cats in the USA with a mean prevalence of 16% (95%
conﬁdence interval 10% to 22%), with increasing age, geographic
location, and being male as risk factors for GHV1 qPCR detection
(Troyer et al., 2014). In this study, we investigated whole blood
from client-owned or shelter cats from Australia and Singapore
and found that FcaGHV1 DNA was also present in these popula-
tions at similar prevalence rates. Sequence analysis revealed
identical or nearly identical GHV sequences in cats from all three
continents over a 315 bp region of the genome. The association
between FcaGHV1 infection and health status was also investi-
gated. Risk factor analyses were conducted for populations from
Australia, Singapore and the previously reported USA population.
We also evaluated the effect of FIV infection on FcaGHV1 virus
load, and FcaGHV1 DNA was quantitated in tissues from infected
cats to investigate tissue tropism.
Results
Prevalence and geographic distribution of FcaGHV1
FcaGHV1 DNA was detected in whole blood from domestic cats
from Australia and Singapore (Fig. 1A). The prevalence in Australia,
11.4% (95% conﬁdence interval [CI] 5.9% to 19.1%), was similar to
that in Singapore, 9.6% (95% CI 5.9% to 14.6%) (Fig. 1B). In Australia,
the probability of FcaGHV1 infection did not differ between states;
Queensland, New South Wales and Victoria (D2,87¼2.299,
P¼0.317). In the USA, the prevalence of FcaGHV1 was 19.1% (95%
CI 12.5% to 27.1%), which is slightly higher than previously
reported for a larger population from the USA (see Troyer et al.,
2014 for prevalence differences among states and counties) and
higher than prevalence in Australia or Singapore (D2,373¼5.310,
P¼0.070). The average FcaGHV1 prevalence across all three
countries was 12.8% (95% CI 9.7% to 16.5%).
FcaGHV sequence variation
Partial gB sequences (315 nucleotides) from Australian cats
(GenBank KJ561572) were identical to those from USA. A single,
identical, synonymous nucleotide polymorphism was detected in
all Singapore samples sequenced (GenBank KJ561573). At nucleo-
tide 126 of the published partial FcaGHV1 gB sequence (GenBank
KF840715) (Troyer et al., 2014). cytosine (USA and Australia) is
replaced with thymidine (Singapore).
Effect of FcaGHV1 on health status
Data on health status were available for cats from Australia and
Singapore. FcaGHV1 DNA positive cats were more likely to be
classiﬁed as sick (Table 1). On average, FcaGHV1 DNA positive
domestic cats were 2.82 (95% CI 1.24% to 6.58%) times more likely
to be sick than FcaGHV1 negative cats. An effect of age was
detected on health status too, with older cats being more likely
to be sick (Table 1). There was no association between sex and
health status (Table 1).
Sex, age and copathogens as risk factors for FcaGHV1 detection
Overall (all countries combined), FcaGHV1 detection was posi-
tively associated with individual sex (male4female) and age
(being adult) (Table 2). These ﬁndings were most distinct in
Australia and USA, which is consistent with our recent ﬁndings
(Troyer et al., 2014). A notable difference was found in Singapore
where FcaGHV1 status was unrelated to sex or age (Table 2).
Remarkably, in Australia and USA, the FcaGHV1 positive popula-
tions were 90% (9 of 10) and 100% (21 of 21) male respectively,
where the total population from each country comprised 65.9%
and 56.9% male cats. In contrast, the Singapore FcaGHV1 positive
population was 50% male (7 of 14) in a population that was
47.6% male.
The most striking positive copathogen association was noted
between FIV infection and FcaGHV1 detection in Singapore (Table 2).
In the USA, there were fewer FIV-infected cats tested for FcaGHV1
DNA, and this relationship was not statistically signiﬁcant (Table 2).
Nevertheless, a greater proportion of the FcaGHV1 positive population
in the USA was FIV-infected compared with FcaGHV1 negative cats
Fig. 1. Location of samples (A) and maximum likelihood estimates (795% CIs) (B) of FcaGHV1 prevalence among countries. States within Australia (Queensland, New South
Wales and Victoria from north to south) and the USA (California, Colorado and Florida, from west to east) from which samples were sourced shaded black. Similarly,
Singapore, off the southern tip of the Malaysian peninsular, is shaded black.
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(Table 3). FIV-infected cats from Australia, investigated in a separate
group with a well-deﬁned age and sex-matched control group, had a
signiﬁcantly greater likelihood of having detectable FcaGHV1 relative
to matched controls (D1,52¼8.22, P¼0.004; odds ratio 5.500 [1.69–
20.51]). Of the 27 individuals that were FIV-infected, 15 were also
FcaGHV1 positive whereas, of the 27 FIV-uninfected individuals only
5 were FcaGHV1 positive. Data on another pathogenic feline retro-
virus, FeLV, were available for cats from Singapore. FeLV infection was
signiﬁcantly associated with FcaGHV1 detection in this group.
There were also positive associations between detection of
FcaGHV1 DNA and Mhm or Mhf infection (Table 2). This relation-
ship was signiﬁcant for both hemoplasmas in Singapore and for
Mhf in Australia, but was non-signiﬁcant in the USA. We found no
signiﬁcant relationship between Bartonella spp or T. gondii expo-
sure and detection and FcaGHV1 at any site.
The relationships identiﬁed in Singapore, where FIV status, but
not sex or age, represented a risk factor for FcaGHV1 were
unexpected. This is because it is well established that adult, male
domestic cats are at increased risk from FIV infection in most
international epidemiological studies, including those from Aus-
tralia and USA (Liem et al., 2013; Levy et al., 2006). Reports of risk
factors for FIV infection in Singapore speciﬁcally are not available.
Therefore, we investigated the relationship between sex, age
and FIV status in Singapore to reveal any regional differences.
Interestingly, sex was not a determinant of FIV status in Singapore,
while age was (Sex D1¼1.85, P¼0.174; Age D1¼7.22, P¼0.007,
residual df209). These data demonstrate that being male is a risk
factor for FcaGHV1 infection in geographic regions where being
male is widely reported as a risk factor for FIV infection. This
suggests that being male per se does not necessarily relate to
increased inherent GHV exposure, as would be concluded by
looking only at USA and Australia populations.
Effect of FIV or FeLV infection on FcaGHV1 load
FIV-infected cats from Australia had signiﬁcantly higher
FcaGHV1 loads than matched FIV-uninfected cats (F1,18¼8.25,
P¼0.010, Fig. 2). For cats from Singapore and USA, no signiﬁcant
effect of retrovirus infection on FcaGHV1 load was detected
(USA—FIV F1,19¼0.29, P¼0.6; Singapore—FIV F1¼1.5, P¼0.25, FeLV
F1¼2.04, P¼0.18, residual df14). The difference in observed results
between regions is most likely due to the greater numbers of FIV-
infected cats and the robust control group, matched for age
and sex, in Australia although regional inﬂuences cannot be
fully excluded. Our results suggest that, when cat age and sex
are tightly controlled, FIV infection is accompanied by higher
FcaGHV1 loads.
Quantitative FcaGHV1 tissue distribution
We quantiﬁed FcaGHV1 DNA load in tissues from 3 FIV-infected
cases. Most tissue types yielded at least one positive qPCR result
for FcaGHV1 DNA. Tissues that were consistently positive in all
cases were small intestine, liver and spleen. We detected signiﬁ-
cant individual variability in FcaGHV1 viral loads among tissues
(Fig. 3A) using Chi-square goodness of ﬁt test assuming uniform
tissue distribution (Cat 1 X214¼17,544, Po0.001; Cat 2 X213¼
192,624, Po0.001; Cat 3 X214¼640,129, Po0.001). Differences
were observed between tissues in DNA load, ranging from 88 to
2645 FcaGHV1 DNA copies per million cells. Small intestine was
the only tissue found to have higher than expected viral loads,
relative to the assumption of even distribution among tissues, in
all cats (Fig. 3B). We detected inter-individual variability in
whether viral loads were greater or less than expected for spleen,
bone marrow and kidney (Fig. 3B). For the remaining tissues
examined, FcaGHV1 loads were lower than expected. Notably,
these samples included tumour tissue from two cats with
neoplasia.
Discussion
We have shown that FcaGHV1 infects domestic cats from
Australia and Singapore. Together with our previous ﬁndings from
the USA, this demonstrates that the virus is present on at least
three continents. Sequence comparisons demonstrated a minor
strain difference in a conserved region of the genome in Singapore
Table 1
FcaGHV1 detection and demographic factors associated with health status.a
Deviance df P Deviance df P Deviance df P
Combined Australia Singapore
FcaGHV1 6.138 1 0.013 2.873 1 0.090n 2.948 1 0.086n
Age 26.12 1 o0.001 19.272 1 o0.001 9.762 1 0.002
Sex 0.007 1 0.935 0.257 1 0.612 0.098 1 0.754
Residuals 255 81 173
a Statistics represent outcomes of binomial regression with all predictor variables included in the model. Predictor variables are also binomial (0 or 1), with 1 equal to
male, adult, or a positive FcaGHV1 test result. Bold¼signiﬁcant results (Po0.05).
n trending results (P¼0.05–0.1). Signiﬁcant or trending results represent positive risk factor relationships.
Table 2
Demographic factors and pathogens associated with FcaGHV1 detection.a
Deviance df P Deviance df P
Combined Australia
Sex 18.031 1 o0.001 3.895 1 0.048
Age 10.310 1 0.001 4.991 1 0.025
Bartonella IgG 3.191 1 0.074n 2.188 1 0.139
B. henselae 0.039 1 0.843 2.685 1 0.101
B. clarridgeiae 0.172 1 0.678 0.367 1 0.544
Mhm 20.120 1 o0.001 3.649 1 0.056n
Mhf 6.602 1 0.010 4.032 1 0.045
Residuals 83 343
USA Singapore
Sex 27.183 1 o0.001 0.084 1 0.771
Age 8.750 1 0.003 0.080 1 0.777
FIV Ab 1.108 1 0.292 16.538 1 o0.001
FeLV Ag 4.605 1 0.032
Toxoplama IgG 0.001 1 0.999 0.013 1 0.908
Bartonella IgG 1.780 1 0.182 0.004 1 0.948
B. henselae 1.289 1 0.256 0.166 1 0.684
B. clarridgeiae 0.395 1 0.530 0.255 1 0.614
Mhm 2.984 1 0.084n 9.717 1 0.002
Mhf 0.012 1 0.913 7.899 1 0.005
Residuals 92 166
a Statistics represent outcomes of binomial regression with all variables
included in the model. Variables were also binomial (0 or 1), with 1 equal to male,
adult, or a positive serological or PCR test result. Bold¼signiﬁcant results (Po0.05).
n trending results (P¼0.05–0.1). Signiﬁcant or trending results represent positive
risk factor relationships. Correlated copathogen status is shown in Table S2.
Ab¼antibody, Ag¼ antigen, B. henselae, B. clarridgeiae, Candidatus Mycoplasma
haemominutum (Mhm) and Mycoplasma haemofelis (Mhf) were detected using PCR.
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FcaGHV1 isolates compared with those from Australia and USA.
Comparison of longer sequences from multiple genes will be
informative to reveal the extent of regional heterogeneity. This
resembles a previous observation in GHV-infected bobcats (Lynx
rufus) where several nucleotide substitutions in gB were detected
in LruGHV1 isolates from bobcat populations in Florida compared
with those in California (Troyer et al., 2014). While data from more
locations will be informative, detection of FcaGHV1 DNA in
peripheral blood at a similar prevalence among cats from the ﬁrst
three regions to be investigated supports FcaGHV1 being widely
endemic in domestic cats worldwide.
Our qPCR assay, the ﬁrst diagnostic tool for FcaGHV1, allows
rapid quantitation of FcaGHV1 DNA in clinical samples. While this
assay is highly speciﬁc for FcaGHV1, its sensitivity for detecting
infected individuals has not yet been evaluated. Since latent
infection is characteristic of herpesviruses, qPCR almost certainly
underestimates the true prevalence of FcaGHV1 infection in
domestic cats. In comparison, peripheral EBV DNA load in asymp-
tomatic adult humans is low or undetectable, contrasting with a
seroprevalence of around 95% (Stevens et al., 2001; Rowe et al.,
1997). It is worth noting that serology is therefore unhelpful in
diagnosing EBV-associated disease whereas measurement of EBV
DNA load by qPCR is an important clinical tool in the management
of several EBV-associated disorders (Kimura et al., 2008). For
FcaGHV1, an antibody detection assay will be informative to
identify cats that have been exposed to FcaGHV1 but do not have
DNA detectable in whole blood and may shed further light on
natural routes of transmission.
Our ﬁndings provide insight into potential mechanisms of
natural transmission. The increased infection risk in adult cats
supports our previous contention that horizontal mechanisms of
transmission predominate. Evidence points to transmission of
FcaGHV1 during aggressive territorial behaviour being a credible
route. Territorial behaviour of male wood mice has been suggested
as a major route of natural transmission of murine gammaherpes-
viruses (Knowles et al., 2012). It is plausible that FcaGHV1 shares
common routes of transmission with copathogens identiﬁed as
risk factors. Inoculation of saliva during a cat ﬁght is the major
natural mode of FIV transmission (Yamamoto et al., 1989). There is
now mounting evidence that intercat aggression represents an
important mode of transmission for feline hemoplasmas. Hemo-
plasma DNA is found in saliva (Dean et al., 2008) and risk factors
for hemoplasma infection include increasing age, male sex, out-
door access, FIV-infection and evidence of a cat bite (Tasker, 2010).
FeLV spreads rapidly through non-aggressive contact between
cohabiting cats but can also be effectively transmitted by biting
(Goldkamp et al., 2008; Hardy et al., 1976). The observed increased
risk of FcaGHV1 detection in FIV or FeLV infection may have an
alternative or additional explanation. Immunosuppression result-
ing from retrovirus coinfection may permit increased replication
of FcaGHV1. For some cats, this might elevate a peripheral
FcaGHV1 DNA load that is otherwise below the limit of detection
of the qPCR into the detectable range. It should also be considered
that the increased FcaGHV load identiﬁed here in FIV-infection
may increase the risk of transmission from FIV-infected cats if a
higher dose of virus is inoculated in blood or saliva during ﬁghting.
Unique regional considerations may underlie the difference in
risk factors identiﬁed for FcaGHV1 infection in Singapore. Most
notable is the absence of a sex predisposition in Singapore which
contrasts sharply the detection of only a single female cat among
FcaGHV1-infected populations in Australia and USA. Singapore is a
densely-populated, urban environment with a large street cat
population. Street cats live in free-roaming colonies with food
Table 3
Numbers of FcaGHV1 negative and positive individuals associated with each variable, sex, age and co-pathogen status, for regions combined and individually.a
Combined Australia USA Singapore
Negative Positive Negative Positive Negative Positive Negative Positive
Sex Female 152 8 29 1 44 0 79 7
Male 156 38 49 9 37 21 70 8
Age Young 105 6 29 1 19 0 57 5
Adult 214 41 49 9 63 21 102 11
FIV Ab Negative – – – – 79 16 139 6
Positive – – – – 10 5 19 10
FeLV Ag Negative – – – – – – 142 10
Positive – – – – – – 16 6
T. gondii IgG Negative – – – – 88 21 145 15
Positive – – – – 1 0 8 1
Bartonella IgG Negative 244 29 44 4 65 10 135 15
Positive 72 18 30 6 24 11 18 1
B. henselae Negative 300 45 63 10 80 18 157 17
Positive 22 3 11 0 9 3 2 0
B. clarridgeiae Negative 310 45 68 10 85 18 157 17
Positive 12 3 6 0 4 3 2 0
Mhm Negative 269 21 63 6 59 6 147 9
Positive 45 27 11 4 22 15 12 8
Mhf Negative 307 39 74 9 76 16 157 14
Positive 7 9 0 1 5 5 2 3
a Variability in the number of sample combinations for FcaGHV1 and each variable is controlled for in risk factor analysis through reduction to a complete dataset (see
Table 1). Dashed lines indicate variables not evaluated. Ab¼antibody, Ag¼antigen, Mhm¼Candidatus Mycoplasma haemominutum, Mhf¼Mycoplasma haemofelis.
Fig. 2. Effect of FIV infection on FcaGHV1 load for Australian cats. FcaGHV1 loads
are signiﬁcantly higher among FIV-infected cats. Data was obtained from FIV-
infected cats (n¼27) and FIV-uninfected age and sex matched controls (n¼27). All
cats were FeLV-antigen negative.
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provided by persons in the community. Anecdotally, client-owned
cats are commonly derived from the street cat population. Equal
participation of both sexes in territorial aggression, perhaps
related to increased competition for resources, may explain the
absence of a sex predisposition for FcaGHV1 infection in Singa-
pore. In support of this notion, we found male cats in Singapore
were as likely as female cats to be infected with FIV, a virus spread
through biting and ﬁghting. We reported a similar absence of sex
as a risk factor in wild cat GHVs (Troyer et al., 2014), which might
similarly reﬂect more opportunities for spread among intact
female felids with opportunities for territorial disputes. In Singa-
pore, age did not predict FcaGHV1 detection. Fighting at an earlier
age in this region was not supported by FIV risk which was higher
in adults. The association between FcaGHV1 and age should thus
be studied in cat populations from other regions to associate
behaviours relating to disease risk.
Recent data supporting arthropod-borne transmission for a GHV
comes from the ﬁnding that immature ticks, Ixodes ricinus, can
harbour the murine gammaherpesvirus, MuHV4 (MHV68, genus
Rhadinovirus) (Ficova et al., 2011). No signiﬁcant role for ﬂea-borne
transmission of FcaGHV1 is suggested by our data. In contrast to the
copathogens discussed above, the major route of natural inter-cat
transmission of Bartonella spp is indirect, via the ﬂea vector, Ctenoce-
phalides felis, or via ﬂea feces. Bartonella spp exposure or DNA detection
were consistently unrelated to FcaGHV1 infection. Further, the pre-
valence of FcaGHV1 DNA detection in a population selected for having
a live ﬂea burden (Australia) was not signiﬁcantly different from
Singapore cats, none of which had evidence of ﬂea infestation at the
time of sampling. It will be of interest to determine whether
ectoparasites can harbour FcaGHV1 DNA to elucidate their potential
as vectors or the existence of reservoir hosts.
We conducted the ﬁrst investigation of FcaGHV1 DNA tissue loads.
FcaGHV1 exhibits the ability to infect a broad range of tissues, but
displays putative tropism for the small intestine. While ampliﬁcation
of virus from peripheral blood within tissues is expected, this source
would not explain the consistent differences in FcaGHV1 load detected
between regions of the gastrointestinal tract that are similarly
vascularized. Similarly, viral load did not parallel the expected tissue
blood supply in a previous study of ovine gammaherpevirus 2 (OvHV2,
genus Macavirus) tissue distribution in sheep where, for example,
cornea which is avascular, had a higher OvHV2 DNA load than skeletal
muscle (Hussy et al., 2002). In agreement with our observations,
compartmentalization of virus in the small intestine has been reported
in sheep naturally infected with the OvHV2 (Hussy et al., 2002). It
should be noted that one cat had a very high FcaGHV1 DNA load in the
bone marrow. Prior FIV infection may alter FcaGHV1 tissue loads or
even tropism. Future studies including a broad range of tissues in
more cats, including FIV-uninfected cats, will determine the signiﬁ-
cance of these ﬁndings. Of particular interest will be the high FcaGHV1
load in the small intestine in relation to shedding or pathogenesis.
An interesting association between FcaGHV1detection and
health status was identiﬁed, with FcaGHV1 positive cats having
higher odds of being sick. This broad categorization of health
status, even when performed by a veterinarian, will inevitably
result in misclassiﬁcation of some individuals. While this method
is not ideal, it is accepted for epidemiological studies, since full
investigation of individual patients is not practical (Levy et al.,
2006; O’Connor et al., 1991). It was important to also examine the
effect of age and sex on health status since both were strongly
associated with FcaGHV1 status in Australia and the USA. Sex was
not related to health status. That cats older than 2 years were more
likely to be sick than cats aged 6 months to 2 years is perhaps not
surprising. The older group encompasses a greater range of
potential age-associated problems and, in the younger group,
paediatric problems have been excluded. Our ﬁndings do not
prove that FcaGHV1 infection is a cause of poor health in cats.
As described previously with FIV, concurrent illness might result
in escape of chronic FcaGHV1 from latency, providing a greater
likelihood of detecting infection using qPCR methodology. Further
studies of a role for FcaGHV1 in feline disease are warranted.
Our observation that cats coinfected with FIV have higher FcaGHV1
loads than retrovirus-negative cats is intriguingly similar to elevated
EBV loads in HIV-infected people. HIV infection of EBV-infected
individuals is followed by an early rise in EBV load that occurs even
before CD4 counts fall (Piriou et al., 2004). The source of the increased
EBV load is postulated to be proliferation of B cells (memory B cells
being the reservoir of EBV infection), a feature of the HIV-mediated
immune dysregulation (Pietersma et al., 2008). In FIV-infected cats,
polyclonal B-cell stimulation is well documented (Flynn et al., 1994),
indicating the potential for similar mechanisms underlying the
increased FcaGHV1 load observed in FIV- infection. Future studies will
determine whether FcaGHV1 infection in the domestic cat might
represent a natural model for GHV pathogenesis.
Material and methods
Ethics statement
Samples used this study were collected according to the University
of Sydney Animal Ethics Committee approvals (N00/6-2009/1/4985;
N00/7-2013/3/6029), Section 53 of the Animals and Birds Act (Cap 5)
Fig. 3. Tissue tropism of FcaGHV1. (A) Tissue FcaGHV1DNA loads for three cases (denoted by bar shading) and (B) residual viral load scores from the chi-square goodness of
ﬁt analysis supporting tropism in some tissues over others and individual variability among cats.
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Agri-Food and Veterinary Authority of Singapore and the Colorado
State University Animal Care and Use Committee or appropriate
institutional, local, and state agencies (Bevins et al., 2012).
Samples for molecular epidemiological studies
Australia: Whole blood DNA from client-owned, domestic cats
from Eastern Australia was available for FcaGHV qPCR (n¼110)
(Barrs et al., 2010). Data available for analyses were: sex, age
(6 months—2 years or 42 years), neuter status, environment
(indoor only or outdoor access), state of domicile (New South
Wales, Queensland or Victoria), serology for Bartonella spp IgG
(Lappin et al., 2009) and results of PCR assays for Mycoplasma
haemofelis (Mhf), Candidatus Mycoplasma haemominutum (Mhm)
(Jensen et al., 2001), Bartonella henselae and Bartonella clarridgeiae
(Jensen et al., 2000). Cats were classiﬁed as either healthy or sick
by the attending veterinarian based on the ﬁndings of a physical
examination and, where available, medical history. The healthy
classiﬁcation included cats that were systemically well but did not
exclude cats with minor problems. Cats classiﬁed as sick were
systemically unwell. All cats had an active ﬂea burden at the time
of sampling.
Whole blood DNA was available from a second group of client-
owned cats from Australia to evaluate FIV as a risk factor for
FcaGHV1 in cats from Australia. These cats were either FIV-
infected cats (n¼27) or age-matched and sex-matched, FIV unin-
fected controls (n¼27) from Australia. This population was distinct
from the Australian cat population described above. “FIV-infected”
and “uninfected” were deﬁned as described previously (Liem et al.,
2013). All cats were seronegative for FeLV antigen.
Singapore: Whole blood DNA from client-owned (n¼106) and
shelter-housed (n¼70) domestic cats from Singapore was avail-
able for FcaGHV1 qPCR (Chan et al., 2013). Data available for
analyses were as for the Australian sample above, with the
addition of serology for FIV antibody, FeLV antigen, (Snap Combo
FIV/FeLV, IDEXX Laboratories, Biomed Diagnostics, Singapore) and
Toxoplasma gondii (T. gondii) IgG (Lappin et al., 1989). FeLV status
was conﬁrmed using PCR (Pinches et al., 2007). All cats were
combed at the time of sampling and found to be free from ﬂeas
and ﬂea feces.
USA: Data not previously analyzed were available for a subset
(n¼88) of free-ranging trap-neuter-release cats of known
FcaGHV1 qPCR status described previously (Troyer et al., 2014;
Bevins et al., 2012). Data available for analyses were: serology for
FIV antibody, T. gondii IgG and Bartonella spp. IgG and results of
PCR assays for B. henselae, B. clarridgeiae, Mhf and Mhm.
Tissues for FcaGHV1 quantitation
Tissues from three adult, male domestic shorthair cats from
Australia were available for FcaGHV qPCR. These client-owned
animals were presented for euthanasia and post-mortem exam-
ination with major problems of high-grade small intestinal lym-
phoma (Case 1), acute gastrointestinal hemorrhage (Case 2) and
pulmonary carcinoma (Case 3). All cats were infected with FIV and
were seronegative for FeLV antigen. Samples from tongue, heart,
lung, skeletal muscle, stomach, small intestine, large intestine,
spleen, liver, pancreas, abdominal lymph node, kidney, bladder
wall and bone marrow, as well as tumor tissue in cases 1
and 3 only, were collected immediately after euthanasia, snap-
frozen and stored at 80 1C.
GAPDH PCR
DNA was extracted from snap frozen tissues using proteinase K
treatment and phenol-chloroform extraction. To conﬁrm the
presence of ampliﬁable template DNA, conventional PCR for
feline glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
performed. Primers designed to amplify an 80 bp product
were (GAPfwd) 50-AAGGCTGAGAACGGGAAAC-30 and (GAPrev)
50-CATTTGATGTTGGCGGGATC-30. PCR reactions contained
500 nM of each primer, 0.2 mM of each deoxynucleotide tripho-
sphate (dNTP), 1.5 mM MgCl2, 1 unit of Platinum Taq DNA Poly-
merase (Life Technologies) and 1 ml of template containing up to
1 mg of DNA in a total volume of 50 ml. Cycling conditions were;
initial denaturation at 94 1C for 3 min followed by 35 cycles of
denaturation at 94 1C for 45 s, primer annealing at 55 1C for 30 s,
extension at 72 1C for 30 s and a ﬁnal extension step at 72 1C for
7 min. Following electrophoresis on 2.5% agarose gels in Tris-
acetate buffer containing 0.5 mg ethidium bromide/ml, the
expected 80 bp product was visualized in all samples following
ultraviolet illumination.
FcaGHV1 qPCR
FcaGHV1 DNA presence and load in DNA from whole blood or
tissues, was detected by qPCR targeting the glycoprotein B (gB)
gene of FcaGHV1, as described previously (Troyer et al., 2014).
Sequencing of FcaGHV gB
To conﬁrm ampliﬁcation of FcaGHV1 and to investigate
sequence variation between geographic regions, 5 FcaGHV1 qPCR
positive DNA samples each from Australian and Singapore were
ampliﬁed by FcaGHV1-speciﬁc PCR. Primers FGHV-F1 (ACCTGCAC-
CAGAGCATGAGA) and FGHV-R1 (TGTCCAGTACGTTAGCCAATCTTT)
ampliﬁed a 360 bp region of the glycoprotein B gene (gB). Reac-
tions contained GoTaq Hot Start Green Master Mix (Promega,
Madison, WI), 400 nM primers, 50–500 ng of template DNA in a
total volume of 50 ml. Cycling conditions were; initial denaturation
at 94 1C for 2 min; followed by 35 cycles of 94 1C for 30 s, 57 1C for
30 s and 72 1C for 30 s; followed by a 5 min extension at 72 1C. The
product was visualized following electrophoresis on a 1.5% agarose
gel with ethidium bromide. PCR products were puriﬁed using a
commercial kit (QIAquick PCR puriﬁcation kit; Qiagen, Valencia,
CA) and sequenced in both directions by the Colorado State
University Proteomics Facility. After removal of primer sequence,
the resulting 315 bp gB sequences were aligned and compared
with the FcaGHV1 sequence obtained from cats in USA (Genbank
KF840715) using BioEdit (Hall, 1999).
Prevalence and geographic distribution of FcaGHV1
Prevalence of FcaGHV1 infection was estimated using maximum
likelihood, with 95% conﬁdence intervals proﬁled. We evaluated
whether the prevalence of FcaGHV1 differed among countries using
a binomial regression, using a likelihood ratio test, based on a chi-
square, to calculate model deviance (D) and P-values (signiﬁcance set
at o0.05). This approach is more robust than a traditional logistic
regression based on a z-statistic. Owing to the spatial distribution of
domestic cat samples within Australia, we also evaluated how the
probability of FcaGHV1 differed among states, again using a binomial
regression. Samples from the USA were also derived across multiple
states and we have previously reported their differences (Troyer et al.,
2014).
Health status
To evaluate possible effects of FcaGHV1 infection on the health
of domestic cats, we analyzed data available from Australia and
Singapore on a qualitative measure of health status, as assessed by
the attending veterinarian (healthy or sick). We used a binomial
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regression to evaluate the effect of FcaGHV1 or age or sex on
health status for Australia and Singapore and for both regions
combined.
Risk factors for FcaGHV1 infection
A variety of predictors of individual FcaGHV1 infection status
were available for analyses, with some variability of available
predictors among countries (Table S1). Prior to undertaking
analyses, and to avoid type-I statistical error associated with
exceeding 1:10 predictor to data ratios (Zar, 2010; Hellard et al.,
2012), we conducted a judicious pre-screening of the available
suite of predictors among countries (Table S1). Following pre-
screening, ‘environment’ and ‘neuter status’ were excluded from
further analysis.
For all countries, we evaluated the effects of individual sex, age
and infection status with Bartonella spp. (PCR ampliﬁcation of
B. henselae, B. clarridgeiae and serology for Bartonella IgG) and
haemoplasma (PCR ampliﬁcation of Mhf and Mhm) on FcaGHV1
status. Owing to the availability of additional copathogen informa-
tion from the USA and Singapore, we also included FIV and
T. gondii status, and FeLV status (Singapore only), while also
maintaining conservative predictor to data ratios. These risk factor
analyses were undertaken using binomial regression for all coun-
tries combined and individually. For cats from Australia, FIV as a
risk factor for FcaGHV1 detection was conducted in a separate
group using binomial regression.
Effect of FIV or FeLV infection on FcaGHV1 load
Peripheral virus load increases in EBV-associated diseases (Kimura
et al., 2008). Increased GHV load is also seen in humans and other
primates following coinfection with immunosuppressive retroviruses
(van Baarle et al., 2002; Rivailler et al., 2004). We investigated whether
a similar association exists between FcaGHV1 and retroviruses FIV (all
regions) and FeLV (Singapore only). For cats from Australia, FcaGHV1
DNA load in FIV-infected cats was compared to load in a robust age
and sex matched FIV-uninfected control group. For cats from Singa-
pore and USA, the control population was not matched. In both cases,
analyses were undertaken by analysis of variance. Prior to analyses,
the distribution of FcaGHV1 load values was evaluated and normalized
by log transformation.
FcaGHV1 tissue DNA load analysis
We used a chi-square goodness of ﬁt test, assuming a null
hypothesis of even distribution of FcaGHV1 load (DNA copies/106
cells) among tissues for each individual cat. Deviations from this
null hypothesis were scrutinized by evaluating the chi-square
residuals, where positive and negative values indicate higher and
lower than expected viral loads respectively. All analyses described
were undertaken in the program R (www.r-project.org) using the
stats, stats4, and ltm packages.
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